Literature DB >> 8985375

Approaches to determine stoichiometry of viral assembly components.

M Trottier1, P Guo.   

Abstract

Due to the rapidity of biological reactions, it is difficult to isolate intermediates or to determine the stoichiometry of participants in intermediate reactions. Instead of determining the absolute amount of each component, this study involved the use of relative parameters, such as dilution factors, percentages probabilities, and slopes of titration curves, that can be more accurately quantified to determine the stoichiometry of components involved in bacteriophage phi29 assembly. This work takes advantage of the sensitive in vitro phage phi29 assembly system, in which 10(8) infectious virions per ml without background can be assembled from eight purified components. It provides a convenient assay for quantification of the stoichiometry of packaging components, including the viral procapsid, genomic DNA, DNA-packaging pRNA, and other structural proteins and enzymes. The presence of a procapsid binding domain and another essential functional domain within the pRNA makes it an ideal component for constructing lethal mutants for competitive procapsid binding. Two methods were used for stoichiometry determination. Method 1 was to determine the combination probability of mutant and wild-type pRNAs bound to procapsids. The probability of procapsids that possess a certain amount of mutant and a certain amount of wild-type pRNA, both with an equal binding affinity, was predicted with the binomial equation [EQUATION IN TEXT] where Z is the total number of pRNAs per procapsid, M is the number of mutant pRNAs bound to one procapsid, and (ZM) is equal to [FORMULA IN TEXT]. With various ratios of mutant to wild-type pRNA in in vitro viral assembly, the percent mutant pRNA versus the yield of virions was plotted and compared to a series of predicted curves to find a best fit. It was determined that five or six copies of pRNA were required for one DNA-packaging event, while only one mutant pRNA per procapsid was sufficient to block packaging. Method 2 involved the comparison of slopes of curves of dilution factors versus the yield of virions. Components with known stoichiometries served as standard controls. The larger the stoichiometry of the component, the more dramatic the influence of the dilution factor on the reaction. A slope of 1 indicates that one copy of the component is involved in the assembly of one virion. A slope larger than 1 would indicate multiple-copy involvement. By this method, the stoichiometry of gp11 in phi29 particles was determined to be approximately 12. These approaches are useful for the determination of the stoichiometry of functional units involved in viral assembly, be they single molecules or oligomers. However, these approaches are not suitable for the determination of exact copy numbers of individual molecules involved if the functional unit is composed of multiple subunits prior to assembly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985375      PMCID: PMC191076     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  A pilot protein participates in the initiation of P22 procapsid assembly.

Authors:  D Thomas; P Prevelige
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

2.  RNA dependence of the bacteriophage phi 29 DNA packaging ATPase.

Authors:  S Grimes; D Anderson
Journal:  J Mol Biol       Date:  1990-10-20       Impact factor: 5.469

3.  Role of RNA in bacteriophage phi 29 DNA packaging.

Authors:  D Anderson; J W Bodley
Journal:  J Struct Biol       Date:  1990 Jul-Sep       Impact factor: 2.867

4.  A small viral RNA is required for in vitro packaging of bacteriophage phi 29 DNA.

Authors:  P X Guo; S Erickson; D Anderson
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

5.  A defined system for in vitro packaging of DNA-gp3 of the Bacillus subtilis bacteriophage phi 29.

Authors:  P Guo; S Grimes; D Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Turn prediction in proteins using a pattern-matching approach.

Authors:  F E Cohen; R M Abarbanel; I D Kuntz; R J Fletterick
Journal:  Biochemistry       Date:  1986-01-14       Impact factor: 3.162

7.  Filter-binding assay for covalent DNA-protein complexes: adenovirus DNA-terminal protein complex.

Authors:  D H Coombs; G D Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

8.  Prohead and DNA-gp3-dependent ATPase activity of the DNA packaging protein gp16 of bacteriophage phi 29.

Authors:  P Guo; C Peterson; D Anderson
Journal:  J Mol Biol       Date:  1987-09-20       Impact factor: 5.469

9.  The proximate 5' and 3' ends of the 120-base viral RNA (pRNA) are crucial for the packaging of bacteriophage phi 29 DNA.

Authors:  C Zhang; C S Lee; P Guo
Journal:  Virology       Date:  1994-05-15       Impact factor: 3.616

10.  Purification, properties and assembly of the neck-appendage protein of the Bacillus subtilis phage phi 29.

Authors:  N Villanueva; J M Lázaro; M Salas
Journal:  Eur J Biochem       Date:  1981-07
View more
  29 in total

1.  Sequence requirement for hand-in-hand interaction in formation of RNA dimers and hexamers to gear phi29 DNA translocation motor.

Authors:  C Chen; C Zhang; P Guo
Journal:  RNA       Date:  1999-06       Impact factor: 4.942

2.  Probing the structure of monomers and dimers of the bacterial virus phi29 hexamer RNA complex by chemical modification.

Authors:  M Trottier; Y Mat-Arip; C Zhang; C Chen; S Sheng; Z Shao; P Guo
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

3.  Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology.

Authors:  Dan Shu; Wulf-Dieter Moll; Zhaoxiang Deng; Chengde Mao; Peixuan Guo
Journal:  Nano Lett       Date:  2004-09       Impact factor: 11.189

Review 4.  Biological Nanomotors with a Revolution, Linear, or Rotation Motion Mechanism.

Authors:  Peixuan Guo; Hiroyuki Noji; Christopher M Yengo; Zhengyi Zhao; Ian Grainge
Journal:  Microbiol Mol Biol Rev       Date:  2016-01-27       Impact factor: 11.056

5.  Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology.

Authors:  Annette Khaled; Songchuan Guo; Feng Li; Peixuan Guo
Journal:  Nano Lett       Date:  2005-09       Impact factor: 11.189

6.  Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.

Authors:  Songchuan Guo; Nuska Tschammer; Sulma Mohammed; Peixuan Guo
Journal:  Hum Gene Ther       Date:  2005-09       Impact factor: 5.695

Review 7.  RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.

Authors:  Peixuan Guo
Journal:  J Nanosci Nanotechnol       Date:  2005-12

8.  DNA packaging motor assembly intermediate of bacteriophage phi29.

Authors:  Jaya S Koti; Marc C Morais; Raj Rajagopal; Barbara A L Owen; Cynthia T McMurray; Dwight L Anderson
Journal:  J Mol Biol       Date:  2008-04-20       Impact factor: 5.469

9.  Binomial distribution for quantification of protein subunits in biological nanoassemblies and functional nanomachines.

Authors:  Huaming Fang; Peng Zhang; Lisa P Huang; Zhengyi Zhao; Fengmei Pi; Carlo Montemagno; Peixuan Guo
Journal:  Nanomedicine       Date:  2014-03-18       Impact factor: 5.307

10.  Sequential action of six virus-encoded DNA-packaging RNAs during phage phi29 genomic DNA translocation.

Authors:  C Chen; P Guo
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.